Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

28.17USD
15 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$28.17
Open
$27.06
Day's High
$28.21
Day's Low
$26.92
Volume
76,473
Avg. Vol
97,873
52-wk High
$40.60
52-wk Low
$15.24

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.58 December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 1 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.20 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 24.20 33.70 14.55 27.20
Quarter Ending Mar-19 4 86.96 172.30 24.70 --
Year Ending Dec-18 4 79.83 88.00 69.21 76.48
Year Ending Dec-19 5 369.92 819.00 148.40 302.27
Earnings (per share)
Quarter Ending Dec-18 5 -0.58 0.03 -0.96 -0.29
Quarter Ending Mar-19 4 -0.31 0.16 -0.69 --
Year Ending Dec-18 4 -2.53 -1.70 -3.15 -1.08
Year Ending Dec-19 4 -0.19 5.88 -2.48 0.80

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 16.82 19.24 2.42 14.41
Quarter Ending Jun-18 12.56 18.32 5.77 45.93
Quarter Ending Mar-18 12.12 17.11 4.98 41.11
Quarter Ending Dec-17 11.92 18.03 6.11 51.28
Quarter Ending Sep-17 11.91 13.45 1.54 12.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 24.20 24.20 35.16 46.03 27.20
Quarter Ending Mar-19 86.96 86.96 52.28 60.60 --
Year Ending Dec-18 79.83 79.83 87.51 103.86 76.48
Year Ending Dec-19 369.92 369.92 407.05 415.18 302.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 3
Quarter Ending Mar-19 0 0 2 0
Year Ending Dec-18 0 0 3 1
Year Ending Dec-19 0 0 2 2
Earnings